The opportunistic fungus Candida albicans is a commensal member of the human microflora and is the most common causative agent of fungal-related disease with particular significance in immunocompromised individuals. Emerging drug resistance is a major problem in Candida, contributed by enzymes involved in the detoxification of xenobiotics and pharmacological agents. One such enzyme, cytochrome b5 reductase (cb5r), has a high pharmacological significance owing to its role in fatty acid elongation, ergosterol (or cholesterol in mammals) biosynthesis, and cytochrome P450-mediated detoxification of xenobiotics. We have compared the kinetic, biochemical, and pharmacological characteristics of C. albicans cb5r isoforms, Cbr1 and Mcr1, as compared to the mammalian control, rat cb5r. We have observed two key structural differences between the fungal and mammalian proteins that may account for decreased thermal stability and inhibitor specificity of C. albicans Cbr1. Substrate binding affinity and catalytic efficiencies, as well as investigation in the flavin-binding environment, were comparable between the fungal and rat enzymes. In S. cerevisiae, CBR1 and MCR1 knockout strains have been challenged with environmental stressors and subsequently shown to have a role in azole and amphotericin B resistance. Our results of potential protein interactions of C. albicans Cbr1 describe proteins involved in the weak acid stress response, implying a novel role of the protein in pathogenicity. Conclusively, this report describes potential inhibitors of the fungal protein, as well as elaborating upon its important role in ergosterol biosynthesis and possible mechanisms of CYP450-mediated drug detoxification.

D. Tech. Food Technology. / Discusses a range of lactobacilli and bifidobacteria were isolated from functional food products and pharmaceutical preparations and also obtained from culture collections. They were then subjected to phylogenetic analysis for accurate identification and classification and the probiotic properties of the organisms was evaluated. The isolates were then screened for inhibitory activity against a range of pathogenic bacteria and Candida albicans strains. Selected isolates that were found to have the necessary inhibitory and probiotic properties were recommended for inclusion in an envisaged synbiotic, maize-based beverage that would, in a subsequent study, be subjected to a nutritional intervention trial aimed at alleviating oral thrush in human patients. The specific objectives: to investigate and illustrate the superiority of rpoA and pheS gene sequencing compared to 16S rRNA gene sequencing in the identification and phylogenic assignment of Lactobacillus isolates ; to determine the precision of selected protein-coding gene sequencing in comparison with 16S rRNA gene sequencing for the discrimination and phylogenetic analysis of Bifidobacterium isolates ; to investigate the probiotic properties of selected bacterial strains in terms of antibacterial activity, anti-Candida activity, acid resistance, bile tolerance and antibiotic resistance ; to determine the potential of Lactobacillus isolates to inhibit the growth of each of seven Candida albicans strains in fermented maize gruel and to establish the factors contributing to Candida inhibition and to determine the antimicrobial and antioxidant activity of intracellular extracts and to elucidate compounds in methanol extracts from selected Lactobacillus strains.

Kinesins are molecular motors that transport intracellular cargos along microtubules (MTs) and influence the organization and dynamics of the MT cytoskeleton. Their force-generating functions arise from conformational changes in their motor domain as ATP is bound and hydrolyzed, and products are released. In the budding yeast Saccharomyces cerevisiae, the Kar3 kinesin forms heterodimers with one of two non-catalytic kinesin-like proteins, Cik1 and Vik1, which lack the ability to bind ATP, and yet they retain the capacity to bind MTs. Cik1 and Vik1 also influence and respond to the MT-binding and nucleotide states of Kar3, and differentially regulate the functions of Kar3 during yeast mating and mitosis. The mechanism by which Kar3/Cik1 and Kar3/Vik1 dimers operate remains unknown, but has important implications for understanding mechanical coordination between subunits of motor complexes that traverse cytoskeletal tracks. In this study, we show that the opportunistic human fungal pathogen Candida albicans (Ca) harbors a single version of this unique form of heterodimeric kinesin and we present the first in vitro characterization of this motor. Like its budding yeast counterpart, the Vik1-like subunit binds directly to MTs and strengthens the MT-binding affinity of the heterodimer. However, in contrast to ScKar3/Cik1 and ScKar3/Vik1, CaKar3/Vik1 exhibits weaker overall MT-binding affinity and lower ATPase activity. Preliminary investigations using a multiple motor motility assay indicate CaKar3/Vik1 may not be motile. Using a maltose binding protein tagging system, we determined the X-ray crystal structure of the CaKar3 motor domain and observed notable differences in its nucleotide-binding pocket relative to ScKar3 that appear to represent a previously unobserved state of the active site. Together, these studies broaden our knowledge of novel kinesin motor assemblies and shed new light on structurally dynamic regions of Kar3/Vik1-like motor complexes that help mediate mechanical coordination of its subunits. / Thesis (Master, Biochemistry) -- Queen's University, 2012-02-29 17:15:03.654

Candida albicans, le pathogène opportuniste le plus commun, peut subir des transitions morphologiques entre la forme levure et la forme hyphe, jouant un rôle dans la formation de biofilm. Le farnésol, un lipide endogène produit par C. albicans, est une molécule de quorum sensing qui inhibe cette transition morphologique. Certaines souches ne répondent pas au farnésol et nous avons vérifié les hypothèses que : 1) l’isolat clinique SC5314, la souche la mieux caractérisée, est un répondeur au farnésol; 2) la germination, la croissance et la formation de biofilm des non répondeurs diffèrent des répondeurs; 3) l’absence de la réponse au farnésol se manifeste en dehors de conditions de culture précises; 4) le farnésol agit via un récepteur nucléaire qui présente des altérations chez les non répondeurs; 5) la différence de la réponse au farnésol entre les souches s’explique par des variations au niveau transcriptionnel de certains gènes (CHK1, HST7, CPH1, GAP1, RAM2 et DPP3). Les non répondeurs produisent un plus grand nombre d’hyphes, forment 60% plus de biofilm et croissent 50% moins vite que les répondeurs. La souche SC5314 se comporte comme un répondeur. L’absence de la réponse au farnésol se manifeste indépendamment des conditions de culture. Cependant, elle ne s’explique pas par une différence dans le niveau d’expression des gènes proposés, excepté pour DPP3 qui est surexprimé chez le non répondeur ATTC® 36802, suggérant ainsi une surproduction de farnésol chez cette souche. De plus, si le farnésol agit via un récepteur nucléaire, il sera d’un type non décrit précédemment. / Candida albicans, the most common fungal pathogen, can undergo morphological transitions between yeast and hyphal forms, which are associated with biofilm formation. Farnesol, an endogenous lipid produced by C. albicans, is a quorum sensing molecule that inhibits this transition. Previous work identified two clinical isolates that didn’t respond to farnesol in colony morphology and biofilm assays. Our goal is to better understand C. albicans response to farnesol using these natural farnesol non responders. We have hypothesized that : 1) clinical isolate SC5314, the most characterized strain, is a farnesol responder; 2) non responders’ germination, growth and biofilm formation are different from those of responders; 3) lack of response to farnesol occurs even outside specific culture conditions; 4) farnesol acts through a nuclear receptor that is altered in non responders; 5) difference in farnesol response between strains is explained by transcriptional variations of specific genes (CHK1, HST7, CPH1, GAP1, RAM2 and DPP3), that were previously shown to be potentially involved in farnesol’s mechanism of action. Non responders produce more hyphae, form 60 % more biofilm and grow 50% slower than responders. The SC5314 strain acts like a responder. Lack of response to farnesol occurs regardless of culture conditions. However, the refractory response to farnesol is not explained by a difference in the proposed genes expression level, except for DPP3 that is upregulated in ATTC® 36802 non responder, suggesting an overproduction of farnesol by this strain. Furthermore, if farnesol acts trough a nuclear receptor, it will be a type not previously described.

The ability of Candida albicans to change morphology plays several roles in its virulence and as a human commensal. The yeast-to-hyphae transition is tightly regulated by several sets of activating and repressing pathways. The DNA-binding proteins Rfg1p, Nrg1p and the global repressor Tup1p are part of the repressors found to regulate this morphogenesis. Knowledge of these repressors is based on extrapolations from homology to S. cerevisiae and from expression studies of mutants in inducing conditions, all of which are indirect means of determining a protein's function. We proposed a genome-wide location study of the Nrg1 and Rfg1 transcription factors to obtain direct data to identify their in vivo targets. Our results suggest different avenues for Nrg1p function and a regulation behaviour diverging from the previously suggested model: Nrg1p acts not only as a repressor but also as a transcription activator. Furthermore it regulates its target genes through binding in their coding regions instead binding to the expected regulatory elements on promoters.

The studies presented in this thesis focus on human and canine models for autoimmune disease, with the main aim to gain new knowledge about disease mechanisms and to further evaluate the dog as a model for autoimmune disease. Autoimmune Polyendocrine Syndrome type 1 (APS-1) is a hereditary human multiorgan disease caused by mutations in the autoimmune regulator (AIRE) gene. Hallmarks of APS-1 are chronic mucocutaneous candidiasis caused by Candida albicans, together with the autoimmune endocrine disorders hypoparathyroidism and adrenocortical failure. Many human diseases have an equivalent disease in dogs. Because humans share environment, and in part life style with the dogs they provide an interesting model for further genetic studies. Immune responses to Candida albicans in APS-1 patients displayed an increased secretion of the proinflammatory cytokine IL-17A and similar results were also found in AIRE deficient mice. Anticytokine autoantibodies to IL-17A, IL-17F and IL-22 were detected in APS-1 patients, and a radioligand binding assay for measuring these autoantibodies was developed and evaluated. In the canine studies we investigated whether canine diabetes mellitus could serve as a model for human autoimmune diabetes mellitus. Furthermore, we investigated type I IFN responses in Nova Scotia duck tolling retriever dogs with a systemic autoimmune disease resembling human SLE. Four assays were used in search for signs of humoral autoimmunity in diabetic dogs. However, no evidence for a type 1 diabetes-like phenotype in dogs was found. Sera from Nova Scotia duck tolling retrievers suffering from steroid-responsive meningitis arteritis elicited an increased expression of IFN-inducible genes in the canine MDCK cell line. This suggests that these dogs have an IFN signature, as seen in human SLE.

Mon projet de thèse a consisté en l'identification et la caractérisation moléculaire et immunologique de patients présentant une susceptibilité accrue aux infections fongiques par Candida sp. dans le syndrome Mendélien de candidose cutanéo-muqueuse chronique (CCMC).La CCMC est caractérisée par des infections persistantes ou récurrentes de la peau, des ongles et des muqueuses par les champignons Candida, principalement C. albicans. Elle est fréquemment associée à d'autres infections opportunistes dans certaines immunodéficiences primaires ou acquises, ou bien elle peut être associée à un tableau auto-immun. La CCMC peut finalement être isolée (CCMCi) sans autre tableau clinique sévère: la plupart des cas rapportés sont sporadiques, mais il existe également des cas familiaux avec une hérédité mendélienne autosomique principalement dominante (AD) ou plus rarement récessive (AR).Basés sur les données de la littérature, qui démontrent un rôle majeur de l'immunité dépendante des IL-17s dans la résistance aux infections mucocutanées vis-à-vis de C. albicans et nos résultats récents, qui démontrent un défaut de cette immunité dans certaines immunodéficiences primaires associées à une CCMC [les syndromes AD-HIES et AR APS-1, ainsi que chez les patients déficients en CARD9, nous avons émis l'hypothèse que parmi les patients atteints de CCMCi, certains pourraient présenter un défaut génétique affectant spécifiquement l'immunité IL-17-dépendante. Au début de ma thèse, j'ai participé à l'identification des deux premières étiologies génétiques de la CCMCi : le défaut autosomique récessif (AR) complet en IL-17RA et autosomique dominant (AD) en IL-17F. Plus récemment, j'ai identifié la troisième et la plus fréquente étiologie génétique de la CCMC par l'identification de mutations gain de fonction dans le gène STAT1 suite à une approche explorant l'ensemble du génome (séquençage de l'ensemble des exons). Ces mutations engendrent une " hyper-réponse " aux interférons de type I et II et à l'IL-27 qui inhibent la différentiation des lymphocytes T sécréteurs d'IL-17, impliqués dans l'immunité mucocutanée vis-à-vis de C. albicans chez l'homme.En conclusion, nous avons identifié, en 2011, des trois premières étiologies génétiques de la CCMCi, avec les défauts AR en IL-17RA, AD en IL-17F et des mutations gain-de-fonction de STAT1, toutes associées à un défaut de l'immunité dépendante de l'IL-17. Des mutations gain-de-fonction de STAT1 représentent à ce jour la cause génétique la plus fréquente de la CCMCi avec au total 94 patients rapportés dans la littérature depuis 2011. Nous avons ainsi démontré que la CCMCi est une immunodéficience primaire, associée à un défaut de l'immunité réalisée par les IL-17s. Ces travaux ont des implications majeures dans le domaine immunologique avec la description et la caractérisation des mécanismes biologiques impliqués dans l'immunité protectrice spécifique de C. albicans et une meilleure compréhension des mécanismes physiopathologiques associés à une susceptibilité accrue aux infections fongiques, dans des conditions naturelles d'infection ; et dans le domaine médical, avec la possibilité de diagnostics moléculaires, un conseil génétique en cas de diagnostic positif, une meilleure prise en charge des patients.

Thèse (M.Sc.)--Université Laval, 2004. / Bibliogr.: f. 105-110. Publié aussi en version électronique.

Submitted by Fernanda Freire null (fernanda.freire@fosjc.unesp.br) on 2017-12-13T19:59:30Z No. of bitstreams: 1 Tese - Fernanda Freire.pdf: 1272262 bytes, checksum: 11df7d222fe968088750e08ceb6fa488 (MD5) / Submitted by Fernanda Freire null (fernanda.freire@fosjc.unesp.br) on 2017-12-14T11:25:01Z No. of bitstreams: 1 Tese - Fernanda Freire.pdf: 1272262 bytes, checksum: 11df7d222fe968088750e08ceb6fa488 (MD5) / Submitted by Fernanda Freire null (fernanda.freire@fosjc.unesp.br) on 2017-12-14T13:50:30Z No. of bitstreams: 1 Tese - Fernanda Freire.pdf: 1272262 bytes, checksum: 11df7d222fe968088750e08ceb6fa488 (MD5) / Approved for entry into archive by Silvana Alvarez null (silvana@ict.unesp.br) on 2017-12-14T18:37:35Z (GMT) No. of bitstreams: 1 freire_f_dr_sjc.pdf: 1272262 bytes, checksum: 11df7d222fe968088750e08ceb6fa488 (MD5) / Made available in DSpace on 2017-12-14T18:37:35Z (GMT). No. of bitstreams: 1 freire_f_dr_sjc.pdf: 1272262 bytes, checksum: 11df7d222fe968088750e08ceb6fa488 (MD5) Previous issue date: 2017-11-30 / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / Os micro-organismos estão se tornando cada vez mais resistentes aos antimicrobianos e cepas de Candida albicans resistentes aos antifúngicos tem sido isoladas, assim, torna-se importante e necessário a realização de pesquisas que avaliem os efeitos de novos métodos terapêuticos, como a inativação fotodinâmica antimicrobiana (aPDI). Assim, o objetivo deste estudo foi verificar os efeitos da inativação fotodinâmica sobre biofilmes de Candida albicans, avaliando seus efeitos sobre a expressão dos genes TEC1 (fator de transcrição), HWP1 (proteína de parede celular das hifas), EFG1 (regulador transcricional relacionado com a morfogênese), BCR1 (regulador da formação de biofilme e da parede celular), CPH1 (regulador transcricional envolvido na morfogênese) e ALS3 (adesina) de C. albicans. Foram avaliadas 30 amostras isoladas de pacientes portadores de HIV e 30 amostras de pacientes com estomatite protética, quanto a produção de biofilme, peso seco e filamentação. Destas, foram selecionadas as amostras mais virulentas de cada grupo que apresentaram melhor capacidade de formação de biofilme e filamentação. Assim, foi utilizada uma amostra clínica de C. albicans isolada de paciente portador de HIV, uma amostra clínica de C. albicans isolada de paciente com estomatite protética e uma cepa padrão ATCC 18804. A quantificação da expressão dos genes foi relacionada à produção desses genes nas amostras clínicas e na cepa de referência utilizando-se ensaio de PCR em tempo real. Para a aPDI, foram utilizados os fotossensibilizadores azul de metileno a 300 μM e eritrosina a 400 μM sensibilizados com laser de Índio-Gálio-Alumínio-Fósforo de baixa potência (vermelho visível, 660 nm) e LED verde (532 ± 10 nm), respectivamente. Foram avaliados quatro grupos experimentais para a aPDI: a) F+L+: sensibilização com o corante e irradiação com luz; b) F+L-: somente tratamento com o fotossensibilizador; c) F-L+: somente irradiação com luz e d) F-L-: sem sensibilização com o corante e ausência de luz. Os resultados foram analisados por t-test, com um nível de significância de 5%. Após a análise fenotípica, as amostras Ca30 e 39S foram selecionadas para a realização da aPDI. Como esperado, apenas para o grupo F+L+, quando comparado com o grupo F-L-, todos os genes analisados foram sub expressos após a aPDI. O fold-decrease para os genes ALS3, HWP1, BCR1, TEC1, CPH1 e EFG1 foram 0,73; 0,39; 0,77; 0,71; 0,67 e 0,60; para laser, respectivamente, e 0,66; 0,61; 0,50; 0,43; 0,54 e 0,66; para LED, respectivamente. Pode-se concluir que a aPDI mostrou uma redução na expressão dos genes de C. albicans, sugerindo a diminuição de sua virulência. / Micro-organisms are becoming increasingly resistant to antimicrobial agents and Candida albicans resistant strains to antifungal has been isolated, so it is important and necessary to carry out studies that evaluates the effects of new therapeutic methods, such as antimicrobial photodynamic inactivation (aPDI). The objective of this study was verify the effects of aPDI on C. albicans biofilms, evaluating its effects on genes expression: TEC1 (transcription factor), HWP1 (cell wall protein hyphae), EFG1 (transcriptional regulator related to morphogenesis), BCR1 (regulator of biofilm formation and cell wall), CPH1 (transcriptional regulator involved in morphogenesis) and ALS3 (adhesin) of C. albicans. Were evaluated 30 samples isolated from patients with HIV and 30 samples from patients with denture stomatitis, as the production of biofilm, dry weight and filamentation. Of these, the most virulent strains of each group that presented better biofilm formation capacity and filamentation were selected. Therefore, were used a clinical sample of C. albicans isolated from HIV positive patient, a clinical sample of C. albicans isolated from patient with denture stomatitis and a standard strain ATCC 18804. The quantification of gene expression was related to the production of these genes in clinical samples and in the reference strain using PCR assay in real time. For aPDI, were used the photosensitizer methylene blue at 300 uM and erythrosine at 400 uM, sensitized with low power laser Indium-Gallium-AluminumPhosphorus (visible red, 660 nm) and green LED (532 ± 10 nm), respectively. Were evaluated four groups for aPDI: a) P+L+: sensitization with the photosensitizer and irradiation with light; b) P+L-: only treatment with the photosensitizer; c) P-L+: only irradiation with light and d) P-L-: without sensitization with the dye and absence of light. The results were analyzed by t-test, with a significance level of 5%. After the phenotypic analysis, the samples Ca30 and 39 S were selected for aPDI . As expected, only in the group P+L+ when compared with the group P-L-, all analyzed genes were downregulated after aPDI. The fold-decrease for the genes ALS3, HWP1, BCR1, TEC1, CPH1 and EFG1, were 0.73, 0.39, 0.77, 0.71, 0.67 and 0.60, for laser, respectively, and 0.66, 0.61, .050, 0.43, 0.54 and 0.66, for LED, respectively. It could be concluded that aPDI showed a reduction in the expression of C. albicans genes, suggesting its virulence decrease. / 2013/22897-2

Submitted by Rodnei Dennis Rossoni (rodnei.rossoni@fosjc.unesp.br) on 2017-12-11T11:19:52Z No. of bitstreams: 1 Tese_Pronta.pdf: 4361864 bytes, checksum: 4e8e22ae0f0744e73ce578cec2fbcce4 (MD5) / Submitted by Rodnei Dennis Rossoni (rodnei.rossoni@fosjc.unesp.br) on 2017-12-11T18:47:11Z No. of bitstreams: 1 Tese_Pronta.pdf: 4361864 bytes, checksum: 4e8e22ae0f0744e73ce578cec2fbcce4 (MD5) / Submitted by Rodnei Dennis Rossoni (rodnei.rossoni@fosjc.unesp.br) on 2017-12-14T11:25:03Z No. of bitstreams: 1 Tese_Pronta.pdf: 4361864 bytes, checksum: 4e8e22ae0f0744e73ce578cec2fbcce4 (MD5) / Submitted by Rodnei Dennis Rossoni (rodnei.rossoni@fosjc.unesp.br) on 2017-12-14T13:50:32Z No. of bitstreams: 1 Tese_Pronta.pdf: 4361864 bytes, checksum: 4e8e22ae0f0744e73ce578cec2fbcce4 (MD5) / Approved for entry into archive by Silvana Alvarez null (silvana@ict.unesp.br) on 2017-12-18T15:12:51Z (GMT) No. of bitstreams: 1 rossoni_rd_dr_sjc.pdf: 4361864 bytes, checksum: 4e8e22ae0f0744e73ce578cec2fbcce4 (MD5) / Made available in DSpace on 2017-12-18T15:12:51Z (GMT). No. of bitstreams: 1 rossoni_rd_dr_sjc.pdf: 4361864 bytes, checksum: 4e8e22ae0f0744e73ce578cec2fbcce4 (MD5) Previous issue date: 2017-12-04 / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / O estudo da atividade inibitória de Lactobacillus pode contribuir na descoberta de novas estratégias terapêuticas nas infecções por Candida. Nesse contexto, o objetivo desse estudo foi isolar e identificar Lactobacillus da cavidade bucal de indivíduos livres de cárie e avaliar seu potencial de inibição de C. albicans por meio de estudos in vitro e in vivo. Primeiramente, foram avaliados os efeitos de 30 isolados clínicos de Lactobacillus sobre o número de células viáveis (UFC) em biofilme de C. albicans e sobre a formação de hifas. Os isolados que obtiveram os maiores efeitos inibitórios sobre C. albicans foram selecionados para os testes de determinação da biomassa total dos biofilmes pela absorbância do cristal violeta, análise da arquitetura dos biofilmes por microscopia eletrônica de varredura (MEV) e quantificação da expressão de genes de C. albicans (ALS3, HWP1, EFG1 e CPH1) por qPCR. Esses isolados também foram submetidos a estudos in vivo usando os modelos de Galleria mellonella e Caenorhabditis elegans. Para o estudo em G. mellonella, a infecção experimental foi avaliada pela curva de sobrevivência, quantificação da carga fúngica na hemolinfa, densidade hemocitária, quantificação da expressão gênica de peptídeos antifúngicos (Gallerymicina e Galiomicina) e monitoramento da infecção de C. albicans por análise de bioluminescência. No modelo de C. elegans, a infecção foi avaliada por meio dos ensaios de curva de sobrevivência e estudo da filamentação de C. albicans. Os resultados dos ensaios in vitro demonstraram que L. paracasei 28.4, L. rhamnosus 5.2 e L. fermentum 20.4 foram as cepas com maior atividade antimicrobiana sobre os biofilmes de C. albicans. Nessas cepas, todos os genes analisados foram regulados negativamente na associação com Lactobacillus quando comparados com o grupo controle. No estudo in vivo, a injeção de L. paracasei 28.4 em G. mellonella infectadas com C. albicans aumentou a sobrevida das larvas, o número de hemócitos e a expressão de peptídeos antifúngicos, reduzindo assim a UFC de C. albicans. Em C. elegans, L. paracasei 28.4 também foi capaz de aumentar a sobrevida dos vermes infectados com C. albicans e reduzir a filamentação. Conclui-se que L. fermentum 20.4, L. paracasei 28.4 e L. rhamnosus 5.2 tem potencial para serem usados como probióticos na cavidade bucal devido sua ação anti-biofilme e sua regulação negativa dos genes de virulência de C. albicans. L. paracasei 28.4 foi capaz de prolongar a sobrevida nos dois modelos experimentais infectados com C. albicans por apresentarem ação antifúngica e imunomodulatória. / The study of the antifungal activity of Lactobacillus may contribute to the discovery of new therapeutic strategies for Candida infections. In this context, the objective of this study was to isolate and identify Lactobacillus from the oral cavity of caries-free subjects and to evaluate its effects through in vitro and in vivo studies. First, the effects of 30 clinical isolates of Lactobacillus on the number of viable cells (CFU) in biofilms of C. albicans and on hyphae formation were evaluated. The isolates that obtained the highest inhibitory effects on C. albicans were selected for biofilm biomass determination by violet crystal absorbance, analysis of biofilm architecture by scanning electron microscopy (SEM) and quantification of the expression of C. albicans (ALS3, HWP1, EFG1 and CPH1) by real time PCR. These isolates were also submitted to in vivo studies using the Galleria mellonella and Caenorhabditis elegans models. For the study in the model of Galleria mellonella, the experimental infection was evaluated by the survival curve, quantification of the fungal load in the hemolymph, hemocitary density, the gene expression of antifungal peptides (Gallerymicin and Galiomicin) and monitoring of C. albicans infection by bioluminescence analysis. In the Caenorhabditis elegans model, the infection was evaluated by the survival curve assays and the study of C. albicans filamentation. The results of in vitro tests demonstrated that L. paracasei 28.4, L. rhamnosus 5.2 and L. fermentum 20.4 were the strains with the highest antimicrobial activity on the biofilms of C. albicans. In these strains, all analyzed genes were negatively regulated in association with Lactobacillus when compared to the control group. In the in vivo study, the injection of L. paracasei 28.4 into the G. mellonella increased survival of the larvae, the number of hemocytes and the expression of antifungal peptides, thus reducing the CFU of C. albicans. In C. elegans, L. paracasei 28.4 was also able to increase the survival of worms infected with C. albicans and reduce the filamentation. We conclude that L. fermentum 20.4, L. paracasei 28.4 and L. rhamnosus 5.2 have potential to be used as probiotics in the oral cavity due to their anti-biofilm action and their negative regulation of virulence genes of C. albicans. L. paracasei 28.4 was able to prolong survival of both experimental models infected with C. albicans for having antifungal and immunomodulatory action. / 13/25181-8 / 14/12458-4